Division of Neuroscience, Medical Research Institute Ninewells Hospital and Medical School, Dundee University Dundee, UK.
Front Mol Neurosci. 2012 Feb 24;5:22. doi: 10.3389/fnmol.2012.00022. eCollection 2012.
The GluA2 subunit in heteromeric alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor channels restricts Ca(2+) permeability and block by polyamines, rendering linear the current-voltage relationship of these glutamate-gated cation channels. Although GluA2-lacking synaptic AMPA receptors occur in GABA-ergic inhibitory neurons, hippocampal CA1 pyramidal cell synapses are widely held to feature only GluA2 containing AMPA receptors. A controversy has arisen from reports of GluA2-lacking AMPA receptors at hippocampal CA3-to-CA1 cell synapses and a study contesting these findings. Here we sought independent evidence for the presence of GluA2-lacking AMPA receptors in CA1 pyramidal cell synapses by probing the sensitivity of their gated cation channels in wild-type (WT) mice and gene-targeted mouse mutants to philanthotoxin, a specific blocker of GluA2-lacking AMPA receptors. The mutants either lacked GluA2 for maximal philanthotoxin sensitivity, or, for minimal sensitivity, expressed GluA1 solely in a Q/R site-edited version or not at all. Our comparative electrophysiological analyses provide incontrovertible evidence for the presence in wild-type CA1 pyramidal cell synapses of GluA2-less AMPA receptor channels. This article is part of a Special Issue entitled "Calcium permeable AMPARs in synaptic plasticity and disease."
谷氨酸 AMPA 受体通道中的 GluA2 亚基限制了多胺的 Ca(2+)通透性和阻断作用,使这些谷氨酸门控阳离子通道的电流-电压关系呈线性。尽管 GABA 能抑制性神经元中存在缺乏 GluA2 的突触 AMPA 受体,但海马 CA1 锥体神经元突触被广泛认为仅含有 GluA2 包含的 AMPA 受体。关于海马 CA3 到 CA1 细胞突触缺乏 GluA2 的 AMPA 受体的报道引发了争议,并且有一项研究对这些发现提出了质疑。在这里,我们通过探测野生型 (WT) 小鼠和基因靶向小鼠突变体中门控阳离子通道对菲那西汀的敏感性,来寻找 CA1 锥体神经元突触中缺乏 GluA2 的 AMPA 受体存在的独立证据,菲那西汀是一种特异性阻断缺乏 GluA2 的 AMPA 受体的药物。这些突变体要么缺乏 GluA2 以获得最大的菲那西汀敏感性,要么由于 Q/R 位点编辑版本仅表达 GluA1 或根本不表达 GluA1 而具有最小的敏感性。我们的比较电生理分析提供了无可争议的证据,证明在野生型 CA1 锥体神经元突触中存在缺乏 GluA2 的 AMPA 受体通道。本文是特刊“突触可塑性和疾病中钙通透型 AMPAR”的一部分。